Early efficacy of teprotumumab for the treatment of dysthyroid optic neuropathy: A multicenter study

PURPOSE: To study post-interventional findings in patients with dysthyroid optic neuropathy (DON) treated with teprotumumab. OBSERVATIONS: In this multicenter observational Case series, patients with DON were treated with teprotumumab, an insulin-like growth factor I receptor inhibitor (10 mg/kg for...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Am J Ophthalmol Case Rep
Main Authors: Sears, Connie M., Wang, Yao, Bailey, Lucy A., Turbin, Roger, Subramanian, Prem S., Douglas, Raymond, Cockerham, Kimberly, Kossler, Andrea L.
Format: Artigo
Jezik:Inglês
Izdano: Elsevier 2021
Teme:
Case Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8170359/
https://ncbi.nlm.nih.gov/pubmed/34113737
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajoc.2021.101111
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki